XRF Scientific Ltd
ASX:XRF
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.49
2.35
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
XRF
stock under the Base Case scenario is
1.69
AUD.
Compared to the current market price of 2.06 AUD,
XRF Scientific Ltd
is
Overvalued by 18%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for XRF Scientific Ltd.
| JP |
I
|
Ishii Iron Works Co Ltd
TSE:6362
|
|
| US |
|
Parker-Hannifin Corp
NYSE:PH
|
|
| SE |
|
Atlas Copco AB
STO:ATCO A
|
|
| JP |
|
Mitsubishi Heavy Industries Ltd
TSE:7011
|
|
| US |
|
Illinois Tool Works Inc
NYSE:ITW
|
|
| US |
|
Barnes Group Inc
NYSE:B
|
|
| CH |
|
Schindler Holding AG
SIX:SCHP
|
|
| SE |
|
Sandvik AB
STO:SAND
|
|
| FI |
K
|
Kone Oyj
OMXH:KNEBV
|
|
| US |
|
Otis Worldwide Corp
NYSE:OTIS
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Slowing capital expenditure in the global mining sector could hamper demand for XRF Scientific’s specialized labware and flux products, given that a significant portion of its sales relies on resource exploration and development activities.
Rising raw material costs—especially for platinum and other metals used in producing labware—may compress margins, as the company has limited pricing power in a niche market, potentially making sustained profitability growth difficult.
Increasing competition from larger, more diversified scientific equipment suppliers could erode market share if XRF Scientific fails to continuously innovate and differentiate its offerings.
XRF Scientific maintains a strong position in its niche, supplying high-quality fluxes and platinum labware critical for accurate X-ray fluorescence analysis, which should support steady, defense-like demand from major mining and metals customers.
Continued global emphasis on precise elemental analysis in mining, environmental testing, and advanced materials research could drive revenue growth, as stricter regulations and quality standards necessitate reliable labware solutions.
Efficient manufacturing processes and specialized product lines provide healthy margins, enabling the company to invest in R&D and expansion, while its small size can allow for agility in responding to new market opportunities and custom client requests.
Revenue & Expenses Breakdown
XRF Scientific Ltd
Balance Sheet Decomposition
XRF Scientific Ltd
| Current Assets | 42m |
| Cash & Short-Term Investments | 12.2m |
| Receivables | 10.3m |
| Other Current Assets | 19.5m |
| Non-Current Assets | 30.8m |
| PP&E | 11.7m |
| Intangibles | 17.3m |
| Other Non-Current Assets | 1.8m |
| Current Liabilities | 9.5m |
| Accounts Payable | 4.1m |
| Other Current Liabilities | 5.5m |
| Non-Current Liabilities | 3.1m |
| Long-Term Debt | 1.9m |
| Other Non-Current Liabilities | 1.2m |
Free Cash Flow Analysis
XRF Scientific Ltd
| AUD | |
| Free Cash Flow | AUD |
Earnings Waterfall
XRF Scientific Ltd
|
Revenue
|
59.4m
AUD
|
|
Cost of Revenue
|
-30.7m
AUD
|
|
Gross Profit
|
28.8m
AUD
|
|
Operating Expenses
|
-13.9m
AUD
|
|
Operating Income
|
14.8m
AUD
|
|
Other Expenses
|
-4.5m
AUD
|
|
Net Income
|
10.4m
AUD
|
XRF Profitability Score
Profitability Due Diligence
XRF Scientific Ltd's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
Score
XRF Scientific Ltd's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
XRF Solvency Score
Solvency Due Diligence
XRF Scientific Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Score
XRF Scientific Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
XRF Price Targets Summary
XRF Scientific Ltd
According to Wall Street analysts, the average 1-year price target for
XRF
is 2.4 AUD
with a low forecast of 2.37 AUD and a high forecast of 2.47 AUD.
Dividends
Current shareholder yield for
XRF is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
XRF
stock under the Base Case scenario is
1.69
AUD.
Compared to the current market price of 2.06 AUD,
XRF Scientific Ltd
is
Overvalued by 18%.